Please assess the completion status of the following clinical trial:

Trial Title: Microdialysis and Pharmacokinetic Study of TR-701

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Body mass index of 20 to 29 kg/m2~* Agree not to consume any products containing tobacco, alcohol, quinine, grapefruit, caffeine, or high levels of tyramine~* Agree not to use any other medication~* Female subjects must be postmenopausal (for at least 6 months), surgically sterile, abstinent, or, if sexually active, be practicing an effective method of birth control~Exclusion Criteria:~* History of gastric or duodenal ulcer within 1 year before enrollment~* Has known or suspected hypersensitivity or intolerance to heparin, if an indwelling cannula (e.g., heparin lock) is used~* Recent febrile illness (less than 72 hours before the first intake of study medication).~* Significant blood loss (300 mL) or donation of blood within the 60 days before the Screening visit~* Women who are pregnant or breast-feeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Pilot study (Type: EXPERIMENTAL): 3 subjects, open lable, microdialysis single dose.
- Main Study (Type: EXPERIMENTAL): 12 subjects, open label, single dose of 600 mg.

Based on this trial design, predict the completion outcome and termination type (if applicable).